Jing Ai

3.5k citations

128 papers · 2.8k indexed · h-index 30

Co-authors: Meiyu Geng Hong‐Rui Tian Zhong‐Ming Sun Chao‐Ying Gao Yinchun Ji Peng Xia Jian Ding Ao Zhang
Topics: Liver physiology and pathology (31 papers)Fibroblast Growth Factor Research (21 papers)PI3K/AKT/mTOR signaling in cancer (16 papers)
Cited by: Process Chemistry and Technology Inorganic Chemistry Organic Chemistry
Journals: Journal of the American Chemical Society Angewandte Chemie International EditionSHILAP Revista de lepidopterología
Partner nations: China United States Mongolia

In The Last Decade

Jing Ai

121 papers receiving 2.8k citations

Peers

Countries citing papers authored by Jing Ai

Since Specialization

Citations

This map shows the geographic impact of Jing Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Ai more than expected).

Fields of papers citing papers by Jing Ai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Ai. The network helps show where Jing Ai may publish in the future.

Co-authorship network of co-authors of Jing Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Ai. A scholar is included among the top collaborators of Jing Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Ai. Jing Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads 2025 ·Journal of the American Chemical Society ·(unknown),Jian Pan,(unknown),Yiwei Zhang,Chao Wang,(unknown),(unknown),(unknown),(unknown),Rui Jin,Zhiqiang Duan,Mingyue Zheng,Lianghe Mei,Lu Zhou,Minjia Tan,Jing Ai,Xiaojie Lu	14
2	Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors 2022 ·Journal of Medicinal Chemistry ·(unknown),Yunong Zhang,(unknown),(unknown),Peng Xia,Jian Zou,Licheng Zhou,Li Tan,(unknown),Yang Zhou,Hoon Hur,Jing Ai,Zhen Wang,Xiaomei Ren,Zhang Zhang,Ke Ding	15
3	The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation 2021 ·Molecular Cancer Therapeutics ·(unknown),Peng Xia,Yinchun Ji,Yang Dai,Yanfen Fang,Bing Xiong,(unknown),Youhong Hu,Yi Chen,Jing Ai	9
4	<p>Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas</p> 2020 ·Cancer Management and Research ·(unknown),(unknown),Jing Ai,Sheng-Qun Chen,Feng Chen,Chun‐Hui Nie,Xinhua Chen,Guan‐Hui Zhou,Hongliang Wang,(unknown),Baoquan Wang,(unknown),Li Jing,Liming Wu,Shusen Zheng,Junhui Sun	1
5	Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors 2020 ·Acta Pharmaceutica Sinica B ·Xiaowei Wu,(unknown),Rongrong Cui,Yulan Wang,Chunpu Li,Peng Xia,Jihui Zhao,Bao Wang,Yang Dai,Dan Feng,Tianbiao Yang,Hualiang Jiang,Meiyu Geng,Jing Ai,Mingyue Zheng,Hong Liu	26
6	The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors 2018 ·Molecular Cancer Therapeutics ·Xinyi Wang,Jing Ai,Hongyan Liu,Peng Xia,Hui Chen,Yi Chen,Yi Su,Aijun Shen,Xun Huang,Jian Ding,Meiyu Geng	11
7	Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models 2017 ·Molecular Cancer Therapeutics ·Jing Ai,Yi Chen,Peng Xia,Yinchun Ji,Yong Xi,Yanyan Shen,Xinying Yang,Yi Su,Yiming Sun,Yinglei Gao,Yuchi Ma,Bing Xiong,Jingkang Shen,Jian Ding,Meiyu Geng	26
8	c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors 2016 ·Clinical Cancer Research ·Hongyan Liu,Jing Ai,Aijun Shen,Yi Chen,Xinyi Wang,Peng Xia,Hui Chen,Yanyan Shen,Min Huang,Jian Ding,Meiyu Geng	28
9	An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone core 2016 ·European Journal of Medicinal Chemistry ·Zilan Song,(unknown),Yinchun Ji,Xing Li,Yinglei Gao,Jing Ai,Meiyu Geng,Ao Zhang	12
10	A microporous Cu-MOF with optimized open metal sites and pore spaces for high gas storage and active chemical fixation of CO₂ 2016 ·Chemical Communications ·Chao‐Ying Gao,Hong‐Rui Tian,Jing Ai,Lei‐Jiao Li,Song Dang,Ya‐Qian Lan,Zhong‐Ming Sun	132
11	Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure—activity relationship study 2015 ·European Journal of Medicinal Chemistry ·Xiaolong Jiang,Ji Zhou,Jing Ai,Zilan Song,Peng Xia,Xing Li,Yong Xi,Junfeng Guo,Qizheng Yao,Jian Ding,Meiyu Geng,Ao Zhang	15
12	Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d]isoxazole or 3-aminoindazole scaffold 2014 ·Bioorganic & Medicinal Chemistry ·Xiaolong Jiang,Hongyan Liu,Zilan Song,Peng Xia,Yinchun Ji,Qizheng Yao,Meiyu Geng,Jing Ai,Ao Zhang	15
13	Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities 2014 ·ACS Medicinal Chemistry Letters ·Zhiqing Liu,Jing Ai,Peng Xia,Zilan Song,Kui Wu,Jing Zhang,Qizheng Yao,Yi Chen,Yinchun Ji,(unknown),Meiyu Geng,Ao Zhang	27
14	SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo 2014 ·Cancer Letters ·Lu Wang,Jing Ai,Yanyan Shen,Haotian Zhang,Peng Xia,Min Huang,Ao Zhang,Jian Ding,Meiyu Geng	12
15	Discovery of novel type II c-Met inhibitors based on BMS-777607 2014 ·European Journal of Medicinal Chemistry ·Wei Zhang,Jing Ai,(unknown),Peng Xia,Yinchun Ji,Jian Liu,Meiyu Geng,Yingxia Li	25
16	Yhhu3813 is a novel selective inhibitor of c-Met Kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells 2013 ·Acta Pharmacologica Sinica ·(unknown),Jing Ai,(unknown),Yi Chen,Haotian Zhang,Min Huang,Youhong Hu,Jian Ding,Meiyu Geng	15
17	Diketopiperazine alkaloids from a mangrove rhizosphere soil derived fungus Aspergillus effuses H1-1 2012 ·Organic & Biomolecular Chemistry ·Huquan Gao,Weizhong Liu,Tianjiao Zhu,Xiaomei Mo,Attila Mándi,Tibor Kurtán,Jing Li,Jing Ai,Qianqun Gu,Dehai Li	59
18	Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors 2012 ·Bioorganic & Medicinal Chemistry ·Dengyou Zhang,Jing Ai,Zhongjie Liang,Chunpu Li,Peng Xia,Yinchun Ji,Hualiang Jiang,Meiyu Geng,Cheng Luo,Hong Liu	27
19	Discovery of 3H‐Imidazo[4,5‐b]pyridines as Potent c‐Met Kinase Inhibitors: Design, Synthesis, and Biological Evaluation 2012 ·ChemMedChem ·Danqi Chen,Ying Wang,Yuchi Ma,Bing Xiong,Jing Ai,Yi Chen,Meiyu Geng,Jingkang Shen	11
20	The Role of Polymeric Immunoglobulin Receptor in Inflammation-Induced Tumor Metastasis of Human Hepatocellular Carcinoma 2011 ·JNCI Journal of the National Cancer Institute ·Jing Ai,Qingjuan Tang,Yanlin Wu,(unknown),(unknown),(unknown),Yi Chen,Xin Gao,Qingfeng Zhu,(unknown),Qiuming Pan,(unknown),(unknown),Min Huang,(unknown),Yuanzheng He,H. Eric Xu,Jia Fan,Jian Ding,Meiyu Geng	60

About Jing Ai

Jing Ai is a scholar working on Hepatology, Process Chemistry and Technology and Oncology, having authored 128 papers that have together received 2.8k indexed citations. Recurring topics across this work include Liver physiology and pathology (31 papers), Fibroblast Growth Factor Research (21 papers) and PI3K/AKT/mTOR signaling in cancer (16 papers). The work is most often cited by research in Process Chemistry and Technology (144 citations), Inorganic Chemistry (528 citations) and Organic Chemistry (845 citations). Jing Ai has collaborated with scholars based in China, United States and Mongolia. Frequent co-authors include Meiyu Geng, Hong‐Rui Tian, Zhong‐Ming Sun, Chao‐Ying Gao, Yinchun Ji, Peng Xia, Jian Ding, Ao Zhang, Wenhu Duan and Peng Xia. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact